1. Home
  2. IVA vs CLMB Comparison

IVA vs CLMB Comparison

Compare IVA & CLMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVA
  • CLMB
  • Stock Information
  • Founded
  • IVA 2011
  • CLMB 1982
  • Country
  • IVA France
  • CLMB United States
  • Employees
  • IVA N/A
  • CLMB N/A
  • Industry
  • IVA Biotechnology: Pharmaceutical Preparations
  • CLMB Retail: Computer Software & Peripheral Equipment
  • Sector
  • IVA Health Care
  • CLMB Technology
  • Exchange
  • IVA Nasdaq
  • CLMB Nasdaq
  • Market Cap
  • IVA 769.0M
  • CLMB 622.6M
  • IPO Year
  • IVA 2020
  • CLMB N/A
  • Fundamental
  • Price
  • IVA $5.27
  • CLMB $133.55
  • Analyst Decision
  • IVA Strong Buy
  • CLMB Buy
  • Analyst Count
  • IVA 7
  • CLMB 1
  • Target Price
  • IVA $16.57
  • CLMB $136.00
  • AVG Volume (30 Days)
  • IVA 211.2K
  • CLMB 39.5K
  • Earning Date
  • IVA 09-29-2025
  • CLMB 10-29-2025
  • Dividend Yield
  • IVA N/A
  • CLMB 0.51%
  • EPS Growth
  • IVA N/A
  • CLMB 59.50
  • EPS
  • IVA N/A
  • CLMB 4.81
  • Revenue
  • IVA $19,929,536.00
  • CLMB $578,437,000.00
  • Revenue This Year
  • IVA N/A
  • CLMB $28.14
  • Revenue Next Year
  • IVA N/A
  • CLMB $5.89
  • P/E Ratio
  • IVA N/A
  • CLMB $27.76
  • Revenue Growth
  • IVA N/A
  • CLMB 56.44
  • 52 Week Low
  • IVA $2.11
  • CLMB $88.90
  • 52 Week High
  • IVA $7.98
  • CLMB $145.02
  • Technical
  • Relative Strength Index (RSI)
  • IVA 47.78
  • CLMB 51.76
  • Support Level
  • IVA $4.96
  • CLMB $129.81
  • Resistance Level
  • IVA $5.34
  • CLMB $140.27
  • Average True Range (ATR)
  • IVA 0.74
  • CLMB 4.69
  • MACD
  • IVA 0.07
  • CLMB -0.55
  • Stochastic Oscillator
  • IVA 23.86
  • CLMB 53.53

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

About CLMB Climb Global Solutions Inc.

Climb Global Solutions Inc is a cloud-based, value-added IT distribution and solutions company specializing in emerging technologies. It operates across the USA, Canada, and Europe through multiple business units, including Climb Channel Solutions, Sigma, Grey Matter, Interwork, and TechXtend. The company is organized into two reportable operating segments. The Distribution segment distributes technical software to corporate resellers, value-added resellers (VARs), consultants, and systems integrators under the name Climb Channel Solutions. The Solutions segment is a cloud solutions provider and value-added reseller of software, hardware, and services to customers under the name Grey Matter.

Share on Social Networks: